Healthcare Industry News: Haemonetics
News Release - October 17, 2007
Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
BRAINTREE, Mass., and TOKYO, Oct. 17 (HSMN NewsFeed) -- Haemonetics Corporation (NYSE: HAE ) is pleased to announce that Keiko Hattori will join the Company effective October 22, 2007 as President, Haemonetics Japan. Ms. Hattori will replace Haemonetics Japan's current President, Ryoji Sakai, who previously announced plans to retire.Brian Concannon, Haemonetics' Chief Operating Officer, said, "Ms. Hattori has tremendous experience and a proven track record for growing businesses in the Japanese and Asian healthcare markets. She brings a depth of leadership to the Japan organization and our senior management team. We are very excited to have someone of her capabilities joining us."
Ms. Hattori's professional background includes positions of increasing responsibility in sales, marketing, and management at several global healthcare companies. She joined Pharmacia in 1985 as Manager of Regulatory Affairs. She remained with Pharmacia when it was acquired by Amersham and ultimately became President of Amersham Biosciences KK. In 2004, when Amersham was acquired by GE she continued the role. Since then Ms. Hattori has held positions with increasing responsibility in various GE divisions in the U.S. and Asia.
Ms. Hattori, age 55, has a BS in Biochemistry from Tokyo University.
Mr. Concannon added, "I'd also like to thank Ryoji Sakai for his significant contributions to Haemonetics during his 13 years of service, as well as for his leadership in transforming our Japanese organization." Mr. Sakai will remain at Haemonetics through fiscal year end as an Executive Advisor to facilitate a smooth transition.
Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.Haemonetics.com.
Source: Haemonetics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!